SANUWAVE Health, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
SANUWAVE Health, Inc. (SNWV) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $704.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-03-26
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $704.00K.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $704.00K.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $704.00K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $704.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $704.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $704.00K 10-K · filed 2025-03-20 |
| 2023-12-31 | $704.00K 10-K · filed 2024-03-21 |
| 2022-12-31 | $704.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $704.00K 10-K · filed 2022-05-13 |
| 2020-12-31 | $703.89K 10-K · filed 2021-10-21 |
| 2015-12-31 | $306.76K 10-K · filed 2016-03-30 |
| 2013-12-31 | $306.76K 10-K · filed 2014-03-31 |
| 2012-12-31 | $306.76K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |